Cited by 1,793Tuberous Sclerosis Complex ResearchGenetic and rare skin diseases.PI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

The Tuberous Sclerosis Complex

Crino, Peter B., Nathanson, Katherine L., Henske, Elizabeth Petri·2006·New England Journal of Medicine

Open this paper in CoChat — free account

Abstract

The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder affecting children and adults, results from mutations in one of two genes, TSC1 (encoding hamartin) or TSC2 (encoding tuberin). In this article, the current knowledge of the pathogenesis of the disease and its management are discussed.

Integrity signals

Registry

Crossref · 10.1056/nejmra055323

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M. D., Yeung, R. S. W., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
Retracted
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citation
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107

Show all 98 references

Research works printed but not linked: 7

Bourneville DM, 1880, Arch Neurol (Paris), 1, 81
Bjornsson J, 1996, Am J Pathol, 149, 1201
Henske EP, 1996, Am J Hum Genet, 59, 400
Plank TL, 1998, Cancer Res, 58, 4766
Plank TL, 1999, Mod Pathol, 12, 539
Wienecke R, 1996, Oncogene, 13, 913
Liu MY, 2002, Cancer Res, 62, 6475

Sorted by citations

Items 601–700 of 1,001

Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex
Pressey, J. G., Wright, J. M., Geller, J. I., Joseph, D. B., Pressey, C. S., & Kelly, D. R. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22401 · Cited by 31
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 34
Update on the management of familial central nervous system tumor syndromes
Hottinger, A. F., & Khakoo, Y. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0031-5 · Cited by 31
Differentiation of Sporadic Versus Tuberous Sclerosis Complex–Associated Angiomyolipoma
Rabenou, R. A., & Charles, H. W. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.14255 · Cited by 30
Statins in Lymphangioleiomyomatosis. Simvastatin and Atorvastatin Induce Differential Effects on tuberous sclerosis complex 2 –Null Cell Growth and Signaling
Atochina‐Vasserman, E. N., Goncharov, D. A., Volgina, A., Milavec, M., James, M. L., & Krymskaya, V. P. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0203rc · Cited by 30
The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink
Kingswood, J. C., Crawford, P. M., Johnson, S. R., Sampson, J. R., Shepherd, C., Demuth, D. G., Erhard, C., Nasuti, P., Patel, K., Myland, M., et al. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1199432 · Cited by 30
Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
Vergeer, M., de Ranitz‐Greven, W. L., Neary, M. P., Ionescu‐Ittu, R., Émond, B., Duh, M. S., Jansen, F. E., & Zonnenberg, B. A. (2019) · Epilepsia Open · doi:10.1002/epi4.12365 · Cited by 30
Application of induced pluripotent stem cells in epilepsy
Hirose, S., Tanaka, Y., Shibata, M., Kimura, Y., Ishikawa, M., Higurashi, N., Yamamoto, T., Ichise, E., Chiyonobu, T., & Ishii, A. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103535 · Cited by 30
Prenatal MR Imaging Phenotype of Fetuses with Tuberous Sclerosis: An Institutional Case Series and Literature Review
Goergen, S. K., & Fahey, M. C. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7455 · Cited by 30
A multiplexed in vivo approach to identify driver genes in small cell lung cancer
Lee, M. C., Cai, H., Murray, C. W., Li, C., Shue, Y. T., Andrejka, L., He, A., Holzem, A. M. E., Drainas, A. P., Ko, J. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.111990 · Cited by 30
Genotype/phenotype in tuberous sclerosis complex: Associations with clinical and radiologic manifestations
Kothare, S. V., Singh, K., Hochman, T., Chalifoux, J. R., Staley, B. A., Weiner, H. L., Menzer, K., & Devinsky, O. (2014) · Epilepsia · doi:10.1111/epi.12627 · Cited by 30
The pathophysiology of tuberous sclerosis complex
Crino, P. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02438.x · Cited by 30
Self-citation
Medical and surgical management of primary cardiac tumours in infants and children
Padalino, M. A., Reffo, E., Cerutti, A., Favero, V., Biffanti, R., Vida, V. L., Stellin, G., & Milanesi, O. (2013) · Cardiology in the Young · doi:10.1017/s104795111300022x · Cited by 30
Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor
Siroky, B. J., Towbin, A. J., Trout, A. T., Schäfer, H., Thamann, A., Agricola, K. D., Tudor, C., Capal, J. K., Dixon, B. P., Krueger, D. A., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.05.015 · Cited by 30
Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec
Kristof, A. S., Li, P. Z., Major, P., & Landry, J. (2015) · CHEST Journal · doi:10.1378/chest.14-3095 · Cited by 29
Progressive multifocal cystlike cortical tubers in tuberous sclerosis complex: Clinical and neuropathologic findings
Chu, C. J., Frosch, M. P., Grant, P. E., & Thiele, E. A. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02193.x · Cited by 29
Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex
Peces, R., Peces, C., Cuesta-López, E., Perez-Duenas, V., Vega-Cabrera, C., Azorín, S., & Selgas, R. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq456 · Cited by 29
From Molecular Circuit Dysfunction to Disease
Dulla, C. G., Coulter, D. A., & Žiburkus, J. (2015) · The Neuroscientist · doi:10.1177/1073858415585108 · Cited by 29
Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy
Sun, F., Wei, Y., Li, S., Guo, W., Chen, X., Liu, S., He, J., Yin, Q., Yang, H., & Zhang, C. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0714-y · Cited by 29
Neuronal mTORC1 Is Required for Maintaining the Nonreactive State of Astrocytes
Zhang, Y., Xu, S., Liang, K., Li, K., Zou, Z., Yang, C., Tan, K., Cao, X., Jiang, Y., Gao, T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744482 · Cited by 28
Magnetic resonance imaging of tuberous sclerosis complex with or without epilepsy at 7 T
Sun, K., Cui, J., Wang, B., Jiang, T., Chen, Z., Fei, C., Zhuo, Y., Liang, S., Xue, R., Yu, X., et al. (2018) · Neuroradiology · doi:10.1007/s00234-018-2040-2 · Cited by 29
mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
Ayuk, S. M., & Abrahamse, H. (2019) · Cells · doi:10.3390/cells8050431 · Cited by 30
Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management
Gomella, P. T., Linehan, W. M., & Ball, M. W. (2021) · Genes · doi:10.3390/genes12020261 · Cited by 30
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong, D., & Iakoucheva, L. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02356-y · Cited by 32
Evidence for population variation in TSC1 and TSC2 gene expression
Jentarra, G. M., Rice, S. G., Olfers, S., Saffen, D. W., & Narayanan, V. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-29 · Cited by 29
Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1)in mice and zebrafish
Valvezan, A. J., Huang, J. Y., Lengner, C. J., Pack, M. A., & Klein, P. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012625 · Cited by 31
Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality
Ma, A., Wang, L., Gao, Y., Chang, Z., Peng, H., Zeng, N., Gui, Y.-S., Tian, X., Li, X., Cai, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt456 · Cited by 31
Localization of the Epileptogenic Foci in Tuberous Sclerosis Complex: A Pediatric Case Report
Hunold, A., Haueisen, J., Ahtam, B., Doshi, C., Harini, C., Camposano, S. E., Warfield, S. K., Grant, P. E., Okada, Y. C., & Papadelis, C. L. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00175 · Cited by 28
Epilepsy in young Tsc1+/− mice exhibits age‐dependent expression that mimics that of human tuberous sclerosis complex
Gataullina, S., Lemaire, É., Wendling, F., Kamińska, A., Françoise Watrin, A., Riquet, A., Ville, D. M., Moutard, M., Martin, A. D. S., Napuri, S., et al. (2016) · Epilepsia · doi:10.1111/epi.13325 · Cited by 29
Tumors and tumor-like proliferations of fibrous and related tissues
Weedon, D. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3485-5.00035-8 · Cited by 29
Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
Cox, R. L., de Anda, F. C., Mangoubi, T., & Yoshii, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00409 · Cited by 29
Functional characterisation of the TSC1–TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex
Nellist, M. D., Sancak, Ő., Goedbloed, M., Adriaans, A. E., Wessels, M. W., Maat‐Kievit, A., Baars, M. J. H., Dommering, C. J., van den Ouweland, A., & Halley, D. J. J. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-10 · Cited by 29
Conditional and domain‐specific inactivation of the Tsc2 gene in neural progenitor cells
Fu, C., & Ess, K. C. (2013) · genesis · doi:10.1002/dvg.22377 · Cited by 27
Comparative analysis ofTsc1andTsc2single and double radial glial cell mutants
Mietzsch, U., McKenna, J. T., Reith, R. M., Way, S. W., & Gambello, M. J. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23380 · Cited by 28
A Cell Type-Specific Expression Signature Predicts Haploinsufficient Autism-Susceptibility Genes
Zhang, C., & Shen, Y. (2016) · Human Mutation · doi:10.1002/humu.23147 · Cited by 25
CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
Lee, S. H., Park, Y., Jin, Y. B., Kim, S., & Hur, J. K. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.008 · Cited by 29
Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis.
Cabrera-López, C., Martí, T., Catalá, V., Torres, F., Mateu, S., Ballarín, J., & Torrá, R. (2011) · PubMed · doi:10.3265/nefrologia.pre2011.apr.10812 · Cited by 28
Complex single gene disorders and epilepsy
Merwick, Á., O’Brien, M., & Delanty, N. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03617.x · Cited by 28
Specific Disruption of Tsc1 in Ovarian Granulosa Cells Promotes Ovulation and Causes Progressive Accumulation of Corpora Lutea
Huang, L., Wang, Z.-B., Jiang, Z.-Z., Hu, M., Lin, F., Zhang, Q.-H., Luo, Y.-B., Hou, Y., Zhao, Y. X., Fan, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054052 · Cited by 28
Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex
Friedman, D., Bogner, M., Menzer, K., & Devinsky, O. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.12.033 · Cited by 28
The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex
Chalifoux, J. R., Perry, N. N., Katz, J. S., Wiggins, G. C., Roth, J., Miles, D. K., Devinsky, O., Weiner, H. L., & Milla, S. S. (2013) · Journal of Neurosurgery Pediatrics · doi:10.3171/2012.12.peds12338 · Cited by 28
The molecular biology of WHO grade I astrocytomas
Marko, N. F., & Weil, R. J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos257 · Cited by 28
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis
Budde, K., Zonnenberg, B. A., Frost, M., Cheung, W. K., Urva, S., Brechenmacher, T., Stein, K. F., Chen, D., Kingswood, J. C., & Bissler, J. J. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12834 · Cited by 28
Pediatric Renal Angiomyolipomas in Tuberous Sclerosis Complex
Warncke, J. C., Brodie, K. E., Grantham, E. C., Catarinicchia, S. P., Tong, S., Kondo, K. L., & Cost, N. G. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.09.082 · Cited by 28
Rapid regression of large cardiac rhabdomyomas in neonates after sirolimus therapy
Weiland, M. D., Bonello, K., & Hill, K. D. (2017) · Cardiology in the Young · doi:10.1017/s104795111700244x · Cited by 28
Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex
Clement, E. A. V. D. P., Şahin, M., & Peters, J. M. (2018) · Journal of Child Neurology · doi:10.1177/0883073818768309 · Cited by 28
Progressive calcified tuber in a young male with tuberous sclerosis complex
Gallagher, A., Madan, N., Stemmer-Rachamimov, A. O., & Thiele, E. A. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03792.x · Cited by 28
Potential Pharmacological Interventions in Polycystic Kidney Disease
Masoumi, A., Gitomer, B. Y., Kelleher, C. L., & Schrier, R. W. (2007) · Drugs · doi:10.2165/00003495-200767170-00004 · Cited by 28
Crystal structure of the yeast TSC1 core domain and implications for tuberous sclerosis pathological mutations
Sun, W., Zhu, Y. J., Wang, Z., Zhong, Q., Gao, F., Lou, J., Gong, W., & Xu, W. (2013) · Nature Communications · doi:10.1038/ncomms3135 · Cited by 27
Non-invasive label-free imaging analysis pipeline for in situ characterization of 3D brain organoids
Serafini, C. E., Charles, S., Costa, P. C., Niu, W., Cheng, B., Wen, Z., Lu, H., & Robles, F. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-72038-2 · Cited by 31
Progesterone and Estradiol Synergistically Promote the Lung Metastasis of Tuberin-Deficient Cells in a Preclinical Model of Lymphangioleiomyomatosis
Sun, Y., Zhang, E. Y., Lao, T., Pereira, A. M., Li, C., Xiong, L., Morrison, T. A., Haley, K. J., Zhou, X., & Yu, J. J. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0192-z · Cited by 27
An approach to cystic kidney diseases: the clinician's view
Kurschat, C. E., Müller, R., Franke, M., Maintz, D. C., Schermer, B., & Benzing, T. R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.173 · Cited by 29
PGD on a recombinant allele: crossover between the TSC2 gene and ‘linked’ markers impairs accurate diagnosis
Altarescu, G., Eldar‐Geva, T., Brooks, B. A., Margalioth, E. J., Levy‐Lahad, E., & Renbaum, P. (2008) · Prenatal Diagnosis · doi:10.1002/pd.2070 · Cited by 27
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation
Munkley, J., Rajan, P., Lafferty, N. P., Dalgliesh, C., Jackson, R. M., Robson, C. N., Leung, H. Y., & Elliott, D. J. (2013) · Oncotarget · doi:10.18632/oncotarget.1405 · Cited by 27
Cross-sectional Imaging Review of Tuberous Sclerosis
Krishnan, A. S., Kaza, R. K., & Vummidi, D. R. (2016) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2015.12.003 · Cited by 27
Epilepsy treatment patterns among patients with tuberous sclerosis complex
Song, J., Swallow, E., Said, Q., Peeples, M., Meiselbach, M. K., Signorovitch, J., Kohrman, M. H., Korf, B. R., Krueger, D. A., Wong, M. L., et al. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.06.011 · Cited by 27
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care
Annear, N. M. P., Appleton, R. E., Bassi, Z., Bhatt, R. I., Bolton, P., Crawford, P. M., Crowe, A., Tossi, M., Elmslie, F., Finlay, E., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01116 · Cited by 29
Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus
Katz, J. S., Milla, S. S., Wiggins, G. C., Devinsky, O., Weiner, H. L., & Roth, J. (2012) · Journal of Neurosurgery Pediatrics · doi:10.3171/2011.12.peds11418 · Cited by 27
Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice
Daikoku, T., Yoshie, M., Xie, H., Sun, X., Cha, J., Ellenson, L. H., & Dey, S. K. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat016 · Cited by 27
Intracranial Arteriopathy in Tuberous Sclerosis Complex
Boronat, S., Shaaya, E. A., Auladell, M. A., Thiele, E. A., & Caruso, P. A. (2013) · Journal of Child Neurology · doi:10.1177/0883073813492386 · Cited by 27
Huaier aqueous extract sensitizes cells to rapamycin and cisplatin through activating mTOR signaling
Hu, Z., Yang, A., Fan, H., Wang, Y., Zhao, Y., Zha, X., Zhang, H., & Tu, P. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.03.069 · Cited by 27
Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis
Ussavarungsi, K., Hu, X., Scott, J. P., Erasmus, D. B., Mallea, J. M., Alvarez, F., Lee, A. S., Keller, C. A., Ryu, J. H., & Burger, C. D. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.08.014 · Cited by 26
Congenital Cerebral Impairments
Kaufman, D. M., & Milstein, M. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3748-2.00013-x · Cited by 26
Syndromes Predisposing to Pediatric Central Nervous System Tumors: Lessons Learned and New Promises
Villani, A., Malkin, D. M., & Tabori, U. Y. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0244-5 · Cited by 26
Imaging of Disorders Affecting the Bone and Skin
Lew, P. P., Ngai, S. S., Hamidi, R., Cho, J. K., Birnbaum, R., Peng, D., & Varma, R. K. (2014) · Radiographics · doi:10.1148/rg.341125112 · Cited by 26
Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC)
Pollack, S. F., Geffrey, A. L., Thiele, E. A., & Shah, U. S. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37148 · Cited by 26
Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
Major, P. (2011) · Aging · doi:10.18632/aging.100298 · Cited by 25
mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
Jeong, A., & Wong, M. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0708-8 · Cited by 26
Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)
Shepherd, C., Koepp, M. J., Myland, M., Patel, K., Miglio, C., Siva, V., Gray, E. J., & Neary, M. P. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015236 · Cited by 26
Less common manifestations in TSC
Boronat, S., & Barber, I. (2018) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31648 · Cited by 26
Amino acid sensing and regulation of mTORC1
Yan, L., & Lamb, R. F. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.001 · Cited by 28
Angiomyolipoma of the anterior mediastinum
Knight, C. S., Cerfolio, R. J., & Winokur, T. S. (2007) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2006.12.007 · Cited by 26
Genetic Kidney Cancer Syndromes
Ho, T. H., & Jonasch, E. W. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0129 · Cited by 25
Radiological diagnosis of perinephric pathology: pictorial essay 2015
Mitreski, G., & Sutherland, T. (2017) · Insights into Imaging · doi:10.1007/s13244-016-0536-z · Cited by 26
Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex
Jin, F., Jiang, K., Ji, S., Wang, L., Ni, Z., Huang, F., Li, C., Chen, R., Zhang, H., Hu, Z., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw397 · Cited by 26
Arthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00168-3 · Cited by 26
Lung ultrasound has limited diagnostic value in rare cystic lung diseases: a cross-sectional study
Davidsen, J. R., Bendstrup, E. M., Henriksen, D. P., Graumann, O., & Laursen, C. B. (2017) · European Clinical Respiratory Journal · doi:10.1080/20018525.2017.1330111 · Cited by 26
Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing
Gu, X., Han, L., Chen, J., Wang, J., Hao, X., Zhang, Y., Zhang, J., Ge, S., & He, Y. (2018) · Medicine · doi:10.1097/md.0000000000010112 · Cited by 26
Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis
Gopalakrishnan, V., Yao, J., Steagall, W. K., Avila, N. A., Taveira‐DaSilva, A. M., Stylianou, M. P., Chen, M. Y., & Moss, J. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.004 · Cited by 26
Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147bin vitro
Broekaart, D. W. M., van Scheppingen, J., Anink, J. J., Wierts, L., Hof, B. V. H., Jansen, F. E., Spliet, W. G. M., van Rijen, P. C., Kamphuis, W. W., de Vries, H. E., et al. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12572 · Cited by 25
Diffuse Cystic Lung Diseases
Obaidat, B., Yazdani, D., Wikenheiser‐Brokamp, K. A., & Gupta, N. (2019) · Respiratory Care · doi:10.4187/respcare.07117 · Cited by 26
Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex
Barone, S., Zahedi, K. A., Brooks, M., Henske, E. P., Yang, Y., Zhang, E. Y., Bissler, J. J., Yu, J. J., & Soleimani, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020190118 · Cited by 26
Self-citation
TSC2 Deficiency Increases PTEN via HIF1α
Mahimainathan, L., Ghosh‐Choudhury, N., Venkatesan, B. A., Das, F., Mandal, C. C., Dey, N., Habib, S. L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028860 · Cited by 26
Cancer and the Kidney: The Growth of Onco-nephrology
Perazella, M. A., Berns, J. S., & Rosner, M. H. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.09.002 · Cited by 26
Systemic Disease and the Skin
Cox, N. H., & Coulson, I. H. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch62 · Cited by 27
Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction
Hoogeveen-Westerveld, M., Exalto, C., Maat-Kievit, A., van den Ouweland, A., Halley, D., & Nellist, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.004 · Cited by 25
Atteintes rénales de la sclérose tubéreuse de Bourneville : recommandations de prise en charge
Rouvière, O., Nivet, H., Grenier, N., Laurent Zini, A., & Lechevallier, É. (2012) · The French Journal of Urology · doi:10.1016/j.purol.2012.03.006 · Cited by 25
Periventricular Heterotopia: Shuttling of Proteins through Vesicles and Actin in Cortical Development and Disease
Sheen, V. L. (2012) · Scientifica · doi:10.6064/2012/480129 · Cited by 25
Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder
Runge, K., van Elst, L. T., Maier, S. J., Nickel, K., Denzel, D., Matysik, M., Kuzior, H., Robinson, T., Blank, T., Dersch, R. S., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10060355 · Cited by 27
Lymphangioleiomyomatosis: a metastatic lung disease
Kundu, N., & Holz, M. K. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00202.2022 · Cited by 25
Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression
Mango, D., & Ledonne, A. (2023) · Cells · doi:10.3390/cells12121588 · Cited by 25
Synaptic Plasticity in Mouse Models of Autism Spectrum Disorders
Chung, L., Bey, A. L., & Jiang, Y. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.369 · Cited by 27
Renal Cell Neoplasms Contain Shared Tumor Type–Specific Copy Number Variations
Krill-Burger, J. M., Lyons, M. A., Kelly, L. A., Sciulli, C., Petrosko, P., Chandran, U. R., Kubal, M. D., Bastacky, S., Parwani, A. V., Dhir, R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.044 · Cited by 24
Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype–genotype study
Boronat, S., Shaaya, E. A., Doherty, C. M., Caruso, P. A., & Thiele, E. A. (2013) · Clinical Genetics · doi:10.1111/cge.12245 · Cited by 25
mTOR treatment in lymphangioleiomyomatosis: the role of everolimus
Yates, D. H. (2016) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1148603 · Cited by 25
Genodermatoses with malignant potential
Holman, J., & Dyer, J. A. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282495939 · Cited by 25
TSC1/TSC2 inactivation inhibits AKT through mTORC1‐dependent up‐regulation of STAT3‐PTEN cascade
Zha, X., Hu, Z., He, S., Wang, F., Shen, H., & Zhang, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.006 · Cited by 25
The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
Hoogeveen-Westerveld, M., van Unen, L., van den Ouweland, A., Halley, D., Hoogeveen, A., & Nellist, M. (2012) · BMC Biochemistry · doi:10.1186/1471-2091-13-18 · Cited by 24
Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review
Fukuda, M., Matsuo, T., Fujimoto, S., Kashii, H., Hoshino, A., Ishiyama, A., & Kumada, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030780 · Cited by 24
Sclerotic bone lesions in tuberous sclerosis complex: A genotype–phenotype study
Boronat, S., Barber, I., & Thiele, E. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38260 · Cited by 24

Authors: Crino, P. B., Nathanson, K. L., & Henske, E. P.
Affiliations: University of Pennsylvania Health System (US)
University of Pennsylvania (US)
Fox Chase Cancer Center (US)
ORCID: Crino, Peter B.
Nathanson, Katherine L.
Henske, Elizabeth Petri
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2006-09-28
Volume: 355
Issue: 13
Pages: 1345-1356
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra055323
OpenAlex: W2383259826
Cited by: 1,793
References: 98
Citations by year: 2026: 39 · 2025: 61 · 2024: 73 · 2023: 61 · 2022: 79 · 2021: 96 · 2020: 94 · 2019: 67 · 2018: 95 · 2017: 101 · 2016: 102 · 2015: 109 · 2014: 119 · 2013: 146 · 2012: 129
FWCI: 7.94
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL60746, R01HL060746)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-51052)
National Institute of Neurological Disorders and Stroke (NS045021, R01NS045021)
Topics: Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tuberous sclerosis complex, TSC1, hamartin, TSC2, tuberin, autosomal dominant disorder, pathogenesis, disease management, multisystem disease
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Estrogens, Female, Humans, Genetic Linkage, Male, Mutation, Protein Kinases, Tuberous Sclerosis, Signal Transduction, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Tuberous Sclerosis Complex

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks